Clinical studies
Number of included patients
Updated 08-05-2025
WARD Medical RCT (n=300)
100%
WARD Surgery RCT (n=400)
100%
WARD glucose validation (N=60)
100%
WARD Surgery RCT II (n=504)
99%
WARD Home II (n=120)
72%
WARD Glucose RCT (N=200)
71%
WARD Prospective study (n=3095)
19%
WARD Fase 1 (N=100)
8%
WARD International
- Project status: Completed
- This study will be an international multicentre prospective…
- Each site can include up to 20 patients…
- Multicenter
WARD Glucose Validation
- Project status: Completed
- Prospective study/cohort
- 60 participants
- Multicenter
WARD Home Pilot
- Project status: Completed
- Prospective study/cohort
- 80 participants
- Bispebjerg Hospital and the patient’s own homes
WARD Surgery RCT II
- Project status: Completed
- Randomized Controlled Trial
- 504 participants
- Multicenter
WARD Surgical RCT
- Project status: Completed
- Randomized Controlled Trial
- 400 participants
- Multicenter
WARD Medical RCT
- Project status: Completed
- Randomized Controlled Trial
- 300 participants
- Multicenter
WARD Fase 1
- Project status: Ongoing
- Non-randomized, non-controlled interventional trial
- 100 participants
- Rigshospitalet, Copenhagen
WARD Glucose RCT
- Project status: Ongoing
- Prospective study/cohort
- 200 participants
- Multicenter
WARD Home
- Project status: Ongoing
- Prospective study/cohort
- 120 participants
- Multicenter